Annex Table 2.
Flowchart defining the study population, for each reporting year 2015 to 2021
Source: InGef Research Database
| 2015 N |
2016 N |
2017 N |
2018 N |
2019 N |
2020 N |
2021 N |
|
|---|---|---|---|---|---|---|---|
| Persons, insured for at least 1 day | 6,782,717 | 6,915,843 | 6,947,163 | 7,001,805 | 7,060,976 | 7,064,881 | 7,121,060 |
| Observable from 1.1. or birth until 31.12. | 6,266,021 | 6,250,948 | 6,388,730 | 6,466,985 | 6,507,621 | 6,499,962 | 6,308,820 |
| Observable in the previous year from 1.1. or birth to 31.12. | 5,982,031 | 5,979,836 | 6,024,269 | 6,159,233 | 6,223,408 | 6,224,301 | 6,011,637 |
| No outpatient or inpatient diabetes diagnosis and no prescription of an antidiabetic drug | 5,465,174 | 5,454,276 | 5,490,349 | 5,616,459 | 5,671,939 | 5,668,763 | 5,478,769 |